Table 1.
Demographic and clinical characteristics of the study’s participants (n = 124)
| Characteristics | Valuesa |
|---|---|
| Age (years) | 65.80 ± 8.25 (50–85) |
| Sex, n (%): men/women | 29 (23%) / 95 (77%) |
| Height (m) | 1.64 ± 0.08 (1.50–1.83) |
| Weight (kg) | 76.14 ± 15.57 (48–135) |
| Body mass index (kg/m2) | 28.07 ± 4.77 (17.4–45.6) |
| Dominant, n (%): right/left | 104 (84%) / 20 (16%) |
| Affected hip, n (%): right/left | 68 (55%) / 56 (45%) |
| Nocturnal pain, n (%): no/yes | 61 (49%) / 63 (51%) |
| Morning stiffness, n (%): no/yes | 48 (39%) / 76 (61%) |
| Assistive device, n (%): no/yes | 100 (81%) / 24 (19%) |
|
Kellgren–Lawrence classification of hip osteoarthritis, n (%): Grade 1/2/3/4 |
5 (4.0%) / 18 (14%) / 64 (52%) / 37 (30%) |
| International hip outcome tool (12 items): Greek version’s total score (initial assessment) | 38.17 ± 23.99 (3.3–95.8) |
| Lower extremity functional scale: Greek version’s total score | 40.64 ± 17.84 (4.0–80.0) |
| Modified Harris hip score: Greek version’s total score | 61.4 ± 18.76 (5.3–51.8) |
| 30 s chair-to-stand test (rep) | 8.00 ± 2.66 (2.0–18.0) |
| Timed Up and Go test performance time (s) | 14.55 ± 7.86 (6.1–45.3) |
| 9stairs-Ascent/Descent test performance time (s) | 19.71 ± 9.56 (5.3–51.8) |
aThe values are expressed as Mean ± Standard deviation (SD) and Range for continuous variables and as frequencies (n) and percentages (%) for categorical variables